Cladribine treatment in pediatric-onset multiple sclerosis: real-world clinical outcomes and safety insights - Quiz - MDSpire

Cladribine treatment in pediatric-onset multiple sclerosis: real-world clinical outcomes and safety insights

  • By

  • Esther Ganelin-Cohen

  • Yair Wexler

  • Sraya Kraus

  • Ayal Rozenberg

  • May 1, 2026

  • 0 min

Share

Original Source(s)

Cladribine treatment in pediatric-onset multiple sclerosis: real-world clinical outcomes and safety insights

  • by Esther Ganelin-Cohen, Yair Wexler, Sraya Kraus, Ayal Rozenberg

  • May 1, 2026

Related Content

Patient Safety Events Among Children Receiving Home Health Care

A Molecular Profile Monitoring the Advancement of Non-Muscle Invasive Bladder Carcinoma

The quality of life in Ecuadorian patients with multiple sclerosis and neuromyelitis optica spectrum disorder and their association with anxiety, depression, fatigue, and disability